NCT00524758View on ClinicalTrials.gov

Oculusgen (Ologen) Glaucoma MMC Control in Estonia

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Open Angle GlaucomaAngle Closure GlaucomaUveitis GlaucomaYoung Age GlaucomaNeovascular GlaucomaHigh Risk Patient
Interventions
DEVICE

ologen (oculusgen) collagen matrix

Implant ologen collagen matrix on the top of sclera flap after loose stiched the sclera flap. The traditional trabeculectomy is performed.

DRUG

MMC in Trabeculectomy

MMC in Trabeculectomy

Trial Locations (1)

Unknown

Tartu University Clinics, Tartu

All Listed Sponsors
lead

Pro Top & Mediking Company Limited

INDUSTRY

NCT00524758 - Oculusgen (Ologen) Glaucoma MMC Control in Estonia | Biotech Hunter | Biotech Hunter